RepliCel Life Sciences Inc (OTCBB - OTCQB:REPCF)
| 0.61 Data as of 3:33pm ET |  -0.03 / -4.69%Today’s Change | 0.30 Today|||52-Week Range 1.20 | +32.61% Year-to-Date |
Latest REPCF News | Press Releases
No recent news for RepliCel Life Sciences Inc.
Today’s Trading
| Previous close | 0.64 |
| Today’s open | 0.61 |
| Day’s range | 0.61 - 0.63 |
| Volume | 10,000 |
| Average volume (3 months) | 11,082 |
| Market cap | $30.1M |
| Dividend yield | -- |
Data as of 3:33pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | +20.87% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1,361.70 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MTEXMannatech Inc | -0.08 | -0.71% |
| ECTEEcho Therapeutics In... | -0.12 | -4.38% |
| IDRAIdera Pharmaceutical... | -0.06 | -8.11% |
| --BioZone Pharmaceutic... | 0.00 | 0.00% |
Data as of 3:59pm ET, 06/19/2013
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$3.4M |
| Net profit margin | -- |
Profile
Sector Non-Energy Minerals |
Industry Precious Metals |
President, Chief Executive Officer & Director David M. Hall |
Chief Financial Officer Thomas A. Kordyback |
Corporate headquarters Vancouver, British Columbia |
Forecasts
